Table 2.

Intraoperative Data of Patients Receiving Des vs. Des/Remi

	Des	Des/Remi	p value
Intraoperative Variables
Duration of anesthesia (hours)	3.28 ± 0.22	3.00 ± 0.37	0.049
Duration of surgery (hours)	2.69 ± 0.26	2.30 ± 0.31	0.005
Maximum maternal heart rate (beats/min)	122 [116–138]	122 [112–129]	0.49
Minimum maternal heart rate (beats/min)	62 [58–72]	52 [50–54]	0.005
Maximum maternal MAP	109 [103–118]	103 [100–119]	0.17
Minimum maternal MAP	67 [63–69]	63 [58–65]	0.075
Case-average end-tidal desflurane	11.0 ± 1.2%	6.7 ± 2.1%	<0.001
Maximum end-tidal desflurane	13.1 ± 1.2%	7.9 ± 2.2%	<0.001
Total MAC-hour desflurane exposure **	4.5 ± 0.7	2.4 ± 1.0	<0.001
Case-average phenylephrine rate (mcg/min)	53 ± 10	36 ± 14	0.004
Total fentanyl dose prior to uterine closure (mcg)	0 [0–0]	250 [250–250]	<0.001
Case-average remifentanil dose (mcg/kg/min) #	0 [0–0]	0.3 [0.2–0.4]	<0.001
Total glycopyrrolate dose (mg)	0.4 [0–0.6]	0.6 [0.4–0.8]	0.025
Estimated blood loss (mL)	300 [100–300]	100 [50–150]	0.022
Colloid volume (L)	0.5 [0.5–1.0]	0.5 [0–1.0]	0.60
Crystalloid volume (L)	1.3 ± 0.5	1.0 ± 0.6	0.26
Reversal of umbilical artery end diastolic flow	3 (27%)	2 (18%)	>0.99*
Incidence of fetal bradycardia	0	0	>0.99

Data are displayed as mean ±SD, median [interquartile range] or number (percent).

^*Categorical variables were compared with Fishers’ Exact Test due to small sample size

^**Exposure time from procedure start to procedure end